BEMA ACQUISITION CONSENT, AMENDMENT, AND WAIVERBema Acquisition Consent, Amendment, and Waiver • September 10th, 2007 • Biodelivery Sciences International Inc • Pharmaceutical preparations • New York
Contract Type FiledSeptember 10th, 2007 Company Industry JurisdictionThis BEMA ACQUISITION CONSENT, AMENDMENT, AND WAIVER (the “Consent”) is entered this September 5, 2007 (the “Consent Date”) by BioDelivery Sciences International, Inc. (“BDSI”), its wholly-owned subsidiary Arius Pharmaceuticals, Inc. (“Arius”), BDSI’s wholly-owned subsidiary Arius Two, Inc. (“Arius Two”), and CDC IV, LLC (“CDC”)